Clinicopathological Features and Outcomes of Fibrillary Glomerulonephritis in an Indian Cohort: A Multicentric Study
Authors:
Open Access
- 22 August 2025
- journal article
- Published by Elsevier in Kidney Medicine
- Vol. 7 (10) , 101085
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Updates on the Diagnosis and Management of Fibrillary GlomerulonephritisAdvances in Kidney Disease and Health, 2024
- DNAJB9 Is a Reliable Immunohistochemical Marker of Fibrillary Glomerulonephritis: Evaluation of Diagnostic Efficacy in a Large Series of Kidney BiopsiesBiomedicines, 2022
- Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot studyNephrology Dialysis Transplantation, 2020
- Fibrillary GlomerulonephritisClinical Journal of the American Society of Nephrology, 2019
- Fibrillary Glomerulonephritis: An UpdateKidney International Reports, 2019
- DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary GlomerulonephritisKidney International Reports, 2018
- Clinical Features and Outcomes of a Racially Diverse Population with Fibrillary GlomerulonephritisAmerican Journal of Nephrology, 2017
- End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry CasesAmerican Journal of Nephrology, 2015
- Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic featuresKidney International, 2003